Bregal Sagemount and Silversmith Invest in Vastian to Boost Healthcare Compliance

Bregal Sagemount, a prominent growth-focused private equity firm, has made a strategic growth investment in Vastian, a provider of SaaS-based quality management software for clinical laboratories and hospitals. The transaction, which also includes participation from existing investor Silversmith Capital Partners, aims to accelerate Vastian’s product innovation and commercial expansion as healthcare organizations face increasingly complex regulatory compliance requirements. The deal was announced on May 05, 2026.

Founded in 1995 and headquartered in Lawrenceville, Georgia, Vastian serves over 9,200 healthcare facilities worldwide, supporting more than 2 million clinical professionals. Its system-of-record platform centralizes quality management processes, enabling hospitals and laboratories to manage audit readiness, operational compliance, and regulatory standards such as CAP, CLIA, The Joint Commission, and ISO. Vastian’s platform manages tens of millions of controlled documents, assessments, and inspection events, helping clients reduce cited deficiencies by nearly 80%.

Bregal Sagemount, with offices in New York and Palo Alto and over $11 billion in capital raised, leads the investment. Silversmith Capital Partners, a Boston-based growth equity firm with over $5 billion under management and Vastian’s first institutional investor, also participates in the round. Financial terms of the investment were not disclosed.

Vastian’s CEO emphasized the company’s mission to provide a comprehensive, purpose-built system of record tailored for healthcare quality teams. “Our customers don’t need another point solution,” he said. “They need a platform that removes manual compliance work so teams can focus on patient safety and care quality. This partnership enables us to reach more providers and support higher standards.”

The investment supports Vastian’s efforts to expand its customer base and enhance its platform capabilities. The company plans to leverage the investors’ expertise to optimize go-to-market strategies, accelerate product innovation, and improve operational efficiencies. This aligns with broader industry trends where healthcare providers increasingly seek integrated solutions to manage complex compliance workflows amid evolving regulatory demands.

Vastian’s platform is recognized as the fastest growing quality management software solution in its sector. The company’s proprietary SaaS platform spans document and compliance management, education and continuing education units (CEUs), and readiness assessments to ensure preparedness for certification and regulatory audits.

Bregal Sagemount’s Managing Partner highlighted the firm’s excitement to partner with Vastian’s leadership as the company extends its market position. Silversmith Capital Partners also expressed confidence in Vastian’s growth trajectory, citing the company’s strong team, reliable product, and embedded role in healthcare compliance.

Looking ahead, Vastian aims to scale customer acquisition in hospitals and laboratories globally, enhance platform features to address evolving regulations, and leverage data analytics to improve client outcomes. Integration challenges include aligning strategic priorities between investors and maintaining innovation velocity while scaling operations.

The investment is expected to intensify competitive pressure in the healthcare quality management software market, potentially accelerating industry consolidation and prompting competitors to increase investment in product development and partnerships.

Vastian remains a private equity-backed company focused on delivering a unified, configurable system-of-record platform that supports healthcare providers in managing risk, accountability, and compliance efficiently.